Literature DB >> 29258032

Characterisation of electron beam irradiation-immobilised laccase for application in wastewater treatment.

Elham Jahangiri1, Isabell Thomas2, Agnes Schulze2, Bettina Seiwert3, Hubert Cabana4, Dietmar Schlosser5.   

Abstract

Laccase from Phoma sp. UHH 5-1-03 was cross-linked to polyvinylidene fluoride membranes by electron beam irradiation. Immobilised laccase displayed a higher stability than the non-immobilised enzyme with respect to typical wastewater temperatures, and pH at a range of 5 to 9. Batch tests addressed the removal of pharmaceutically active compounds (PhACs; applied as a mixture of acetaminophen, bezafibrate, indometacin, ketoprofen, mefenamic acid, and naproxen) by both immobilised and non-immobilised laccase in municipal wastewater. High removal rates (>85%) of the most efficiently oxidised PhACs (acetaminophen and mefenamic acid) indicated a high efficiency of the immobilised laccase in wastewater. Continuous elimination of the aforementioned PhACs by the immobilised enzyme in a continuously operated diffusion basket reactor yielded a PhAC removal pattern qualitatively similar to those observed in batch tests. Clearly higher apparent Vmax values and catalytic efficiencies (in terms of both Vmax/S0.5 as well as Vmax/Km values obtained from data fitting according to the Hill and the Michaelis-Menten model, respectively) observed for acetaminophen oxidation by the immobilised compared to the non-immobilised enzyme are in support of a considerably higher functional stability of the immobilised laccase especially in wastewater. The potential influence of acetaminophen on the removal of comparatively less laccase-oxidisable water pollutants such as the antimicrobial triclosan (TCS) was investigated. TCS was increasingly removed upon increasing the initial acetaminophen concentration in immobilised as well as non-immobilised laccase reaction systems until saturation became evident. Acetaminophen was consumed and not recycled during laccase reactions, which was accompanied by the formation of various acetaminophen-TCS cross-coupling products. Nevertheless, the simultaneous presence of acetaminophen (and potentially even more pollutant removal-enhancing laccase substrates) and more recalcitrant pollutants in wastewater represents an interesting option for the efficiency enhancement of enzyme-based wastewater treatment approaches.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acetaminophen; Laccase immobilisation; Micro-pollutants; Pharmaceutically active compounds; Transformation products; Wastewater

Year:  2017        PMID: 29258032     DOI: 10.1016/j.scitotenv.2017.12.127

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  4 in total

1.  Reagent-Free Immobilization of Industrial Lipases to Develop Lipolytic Membranes with Self-Cleaning Surfaces.

Authors:  Martin Schmidt; Andrea Prager; Nadja Schönherr; Roger Gläser; Agnes Schulze
Journal:  Membranes (Basel)       Date:  2022-06-09

2.  Preparation of Gallic Acid-Grafted Chitosan Using Recombinant Bacterial Laccase and Its Application in Chilled Meat Preservation.

Authors:  Meixia Zheng; Chong Zhang; Ying Zhou; Zhaoxin Lu; Haizen Zhao; Xiaomei Bie; Fengxia Lu
Journal:  Front Microbiol       Date:  2018-08-03       Impact factor: 5.640

Review 3.  Laccases: structure, function, and potential application in water bioremediation.

Authors:  Leticia Arregui; Marcela Ayala; Ximena Gómez-Gil; Guadalupe Gutiérrez-Soto; Carlos Eduardo Hernández-Luna; Mayra Herrera de Los Santos; Laura Levin; Arturo Rojo-Domínguez; Daniel Romero-Martínez; Mario C N Saparrat; Mauricio A Trujillo-Roldán; Norma A Valdez-Cruz
Journal:  Microb Cell Fact       Date:  2019-11-14       Impact factor: 5.328

4.  Polyamide-Laccase Nanofiber Membrane for Degradation of Endocrine-Disrupting Bisphenol A, 17α-ethinylestradiol, and Triclosan.

Authors:  Milena Maryskova; Miroslava Rysova; Vit Novotny; Alena Sevcu
Journal:  Polymers (Basel)       Date:  2019-09-25       Impact factor: 4.329

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.